These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38366299)

  • 1. Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.
    Kanellopoulos P; Mattsson A; Abouzayed A; Obeid K; Nock BA; Tolmachev V; Maina T; Orlova A
    EJNMMI Radiopharm Chem; 2024 Feb; 9(1):13. PubMed ID: 38366299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics.
    Abouzayed A; Kanellopoulos P; Gorislav A; Tolmachev V; Maina T; Nock BA; Orlova A
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.
    Obeid K; Kanellopoulos P; Abouzayed A; Mattsson A; Tolmachev V; Nock BA; Maina T; Orlova A
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Kanellopoulos P; Lymperis E; Kaloudi A; de Jong M; Krenning EP; Nock BA; Maina T
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32731473
    [No Abstract]   [Full Text] [Related]  

  • 6. [
    Nock BA; Kaloudi A; Kanellopoulos P; Janota B; Bromińska B; Iżycki D; Mikołajczak R; Czepczynski R; Maina T
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of l-Tryptophan by
    Günther T; Deiser S; Felber V; Beck R; Wester HJ
    J Nucl Med; 2022 Sep; 63(9):1364-1370. PubMed ID: 35027371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [
    Kanellopoulos P; Kaloudi A; Rouchota M; Loudos G; de Jong M; Krenning EP; Nock BA; Maina T
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33256013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
    Lymperis E; Kaloudi A; Sallegger W; Bakker IL; Krenning EP; de Jong M; Maina T; Nock BA
    Bioconjug Chem; 2018 May; 29(5):1774-1784. PubMed ID: 29664606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA
    J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.
    Maina T; Kaloudi A; Valverde IE; Mindt TL; Nock BA
    Nucl Med Biol; 2017 Sep; 52():57-62. PubMed ID: 28636973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.
    Maina T; Bergsma H; Kulkarni HR; Mueller D; Charalambidis D; Krenning EP; Nock BA; de Jong M; Baum RP
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):964-973. PubMed ID: 26631238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Gastrin Releasing Peptide Receptor-Directed [
    Nock BA; Charalambidis D; Sallegger W; Waser B; Mansi R; Nicolas GP; Ketani E; Nikolopoulou A; Fani M; Reubi JC; Maina T
    J Med Chem; 2018 Apr; 61(7):3138-3150. PubMed ID: 29517903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist
    Mitran B; Rinne SS; Konijnenberg MW; Maina T; Nock BA; Altai M; Vorobyeva A; Larhed M; Tolmachev V; de Jong M; Rosenström U; Orlova A
    Int J Cancer; 2019 Dec; 145(12):3347-3358. PubMed ID: 31077356
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.